Dental Health Services Response to COVID-19 in Norway
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Participants
2.2. Questionnaire
2.3. Statistical Analysis
2.4. Ethical Considerations
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Mahase, E. China coronavirus: WHO declares international emergency as death toll exceeds 200. BMJ 2020, 368, m408. [Google Scholar] [CrossRef] [Green Version]
- World Health Organization. Coronavirus Disease (COVID-19) Pandemic. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019?gclid=Cj0KCQjw0YD4BRD2ARIsAHwmKVmNyTZntqHY8mnWiIWPlKpj41bEGY-UjmYkbJ-6mjfBTYlMQrrQLV8aAtDREALw_wcB (accessed on 4 July 2020).
- Gorbalenya, A.E.; Baker, S.C.; Baric, R.S.; de Groot, R.J.; Drosten, C.; Gulyaeva, A.A.; Haagmans, B.L.; Lauber, C.; Leontovich, A.M.; Neuman, B.W.; et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses—A statement of the Coronavirus Study Group. bioRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Drosten, C.; Gunther, S.; Preiser, W.; van der Werf, S.; Brodt, H.R.; Becker, S.; Rabenau, H.; Panning, M.; Kolesnikova, L.; Fouchier, R.A.; et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 2003, 348, 1967–1976. [Google Scholar] [CrossRef]
- Ksiazek, T.G.; Erdman, D.; Goldsmith, C.S.; Zaki, S.R.; Peret, T.; Emery, S.; Tong, S.; Urbani, C.; Comer, J.A.; Lim, W.; et al. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 2003, 348, 1953–1966. [Google Scholar] [CrossRef]
- Peiris, J.S.; Lai, S.T.; Poon, L.L.; Guan, Y.; Yam, L.Y.; Lim, W.; Nicholls, J.; Yee, W.K.; Yan, W.W.; Cheung, M.T.; et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003, 361, 1319–1325. [Google Scholar] [CrossRef] [Green Version]
- World Health Organization. Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003. Available online: https://www.who.int/csr/sars/country/table2004_04_21/en/ (accessed on 3 April 2020).
- Zaki, A.M.; van Boheemen, S.; Bestebroer, T.M.; Osterhaus, A.D.; Fouchier, R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 2012, 367, 1814–1820. [Google Scholar] [CrossRef]
- Zumla, A.; Hui, D.S.; Perlman, S. Middle East respiratory syndrome. Lancet 2015, 386, 995–1007. [Google Scholar] [CrossRef] [Green Version]
- World Health Organization. Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Available online: https://www.who.int/emergencies/mers-cov/en/ (accessed on 3 April 2020).
- Memish, Z.A.; Perlman, S.; Van Kerkhove, M.D.; Zumla, A. Middle East respiratory syndrome. Lancet 2020, 395, 1063–1077. [Google Scholar] [CrossRef]
- World Health Organization. Coronavirus Disease (COVID-19) Situation Dashboard. Available online: https://covid19.who.int/?gclid=Cj0KCQjw0YD4BRD2ARIsAHwmKVmDES0d5vbI7oZRvxKjLOIKwOklzl50XbqKds6rI7mKaAvYUAEBGpIaAopsEALw_wcB (accessed on 3 April 2020).
- Lu, C.W.; Liu, X.F.; Jia, Z.F. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet 2020, 395, e39. [Google Scholar] [CrossRef] [Green Version]
- To, K.K.; Tsang, O.T.; Chik-Yan Yip, C.; Chan, K.H.; Wu, T.C.; Chan, J.M.C.; Leung, W.S.; Chik, T.S.; Choi, C.Y.; Kandamby, D.H.; et al. Consistent detection of 2019 novel coronavirus in saliva. Clin. Infect. Dis. 2020. [Google Scholar] [CrossRef] [Green Version]
- van Doremalen, N.; Bushmaker, T.; Morris, D.H.; Holbrook, M.G.; Gamble, A.; Williamson, B.N.; Tamin, A.; Harcourt, J.L.; Thornburg, N.J.; Gerber, S.I.; et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N. Engl. J. Med. 2020, 382, 1564–1567. [Google Scholar] [CrossRef] [PubMed]
- Bai, Y.; Yao, L.; Wei, T.; Tian, F.; Jin, D.Y.; Chen, L.; Wang, M. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA 2020. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Centers for Disease Control and Prevention. Interim Infection Prevention and Control Guidance for Dental Settings during the COVID-19 Response. Available online: https://www.cdc.gov/coronavirus/2019-ncov/hcp/dental-settings.html (accessed on 8 April 2020).
- Amber Ather, B.; Nikita, B. Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care. J. Endod. 2020, 46, 584–595. [Google Scholar] [CrossRef]
- World Health Organization. Coronavirus Disease (COVID-19) Outbreak: Rights, Roles and Responsibilities of Health Workers, Including Key Considerations for Occupational Safety and Health. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/health-workers (accessed on 4 July 2020).
- Norwegian Institute of Public Health. Statistikk om Koronavirus og COVID-19. Available online: https://www.fhi.no/sv/smittsomme-sykdommer/corona/dags--og-ukerapporter/dags--og-ukerapporter-om-koronavirus/#fylkesoversikt (accessed on 4 July 2020).
- Kamate, S.K.; Sharma, S.; Thakar, S.; Srivastava, D.; Sengupta, K.; Hadi, A.J.; Chaudhary, A.; Joshi, R.; Dhanker, K. Assessing Knowledge, Attitudes and Practices of Dental Practitioners Regarding the COVID-19 Pandemic: A Multinational Study. Dent. Med. Probl. 2020, 57, 11–17. [Google Scholar] [CrossRef] [PubMed]
- Quadri, M.F.A.; Jafer, M.A.; Alqahtani, A.S.; Al Mutahar, S.A.B.; Odabi, N.I.; Daghriri, A.A.; Tadakamadla, S.K. Novel corona virus disease (COVID-19) awareness among the dental interns, dental auxiliaries and dental specialists in Saudi Arabia: A nationwide study. J. Infect. Public Health 2020, 13, 856–864. [Google Scholar] [CrossRef]
- Khader, Y.; Al Nsour, M.; Al-Batayneh, O.B.; Saadeh, R.; Bashier, H.; Alfaqih, M.; Al-Azzam, S.; AlShurman, B.A. Dentists’ Awareness, Perception, and Attitude Regarding COVID-19 and Infection Control: Cross-Sectional Study among Jordanian Dentists. JMIR Public Health Surveill 2020, 6, e18798. [Google Scholar] [CrossRef]
- Ahmed, M.A.; Jouhar, R.; Ahmed, N.; Adnan, S.; Aftab, M.; Zafar, M.S.; Khurshid, Z. Fear and Practice Modifications among Dentists to Combat Novel Coronavirus Disease (COVID-19) Outbreak. Int. J. Environ. Res. Public Health 2020, 17, 2821. [Google Scholar] [CrossRef]
- Duruk, G.; Gümüşboğa, Z.; Çolak, C. Investigation of Turkish dentists’ clinical attitudes and behaviors towards the COVID-19 pandemic: A survey study. Braz. Oral Res. 2020, 34, e054. [Google Scholar] [CrossRef]
- Cagetti, M.G.; Cairoli, J.L.; Senna, A.; Campus, G. COVID-19 Outbreak in North Italy: An Overview on Dentistry. A Questionnaire Survey. Int. J. Environ. Res. Public Health 2020, 17, 3835. [Google Scholar] [CrossRef]
- Consolo, U.; Bellini, P.; Bencivenni, D.; Iani, C.; Checchi, V. Epidemiological Aspects and Psychological Reactions to COVID-19 of Dental Practitioners in the Northern Italy Districts of Modena and Reggio Emilia. Int. J. Environ. Res. Public Health 2020, 17, 3459. [Google Scholar] [CrossRef]
- De Stefani, A.; Bruno, G.; Mutinelli, S.; Gracco, A. COVID-19 Outbreak Perception in Italian Dentists. Int. J. Environ. Res. Public Health 2020, 17, 3867. [Google Scholar] [CrossRef] [PubMed]
- The Workers Who Face the Greatest Coronavirus Risk. Available online: https://www.nytimes.com/interactive/2020/03/15/business/economy/coronavirus-worker-risk.html (accessed on 15 July 2020).
- Norwegian Institute of Public Health. Råd til Tannhelsetjenesten under Covid-19-Pandemien. Available online: https://www.fhi.no/nettpub/coronavirus/helsepersonell/rad-til-tannhelsetjenesten/ (accessed on 4 July 2020).
- Elangovan, S.; Mahrous, A.; Marchini, L. Disruptions during a pandemic: Gaps identified and lessons learned. J. Dent. Educ. 2020. [Google Scholar] [CrossRef]
- Carter, E.; Currie, C.C.; Asuni, A.; Goldsmith, R.; Toon, G.; Horridge, C.; Simpson, S.; Donnell, C.; Greenwood, M.; Walton, G.; et al. The first six weeks-setting up a UK urgent dental care centre during the COVID-19 pandemic. Br. Dent. J. 2020, 228, 842–848. [Google Scholar] [CrossRef] [PubMed]
- Guo, H.; Zhou, Y.; Liu, X.; Tan, J. The impact of the COVID-19 epidemic on the utilization of emergency dental services. J. Dent. Sci. 2020. [Google Scholar] [CrossRef]
- National Health Service. Letters, Updates and Additional Guidance for Dental Teams. Available online: https://www.england.nhs.uk/coronavirus/publication/preparedness-letters-for-dental-care/ (accessed on 4 July 2020).
- Meng, L.; Hua, F.; Bian, Z. Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine. J. Dent. Res. 2020, 99, 481–487. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- World Health Organization. Advice on the Use of Masks in the Context of COVID-19. Available online: https://www.who.int/publications-detail/advice-on-the-use-of-masks-in-the-community-during-home-care-and-in-healthcare-settings-in-the-context-of-the-novel-coronavirus-(2019-ncov)-outbreak (accessed on 4 July 2020).
- World Health Organization. Infection Prevention and Control during Health Care when Coronavirus Disease (COVID-19) is Suspected or Confirmed. Available online: https://www.who.int/publications/i/item/WHO-2019-nCoV-IPC-2020.4 (accessed on 4 July 2020).
- World Health Organization. Considerations for the Provision of Essential Oral Health Services in the Context of COVID-19. Available online: https://www.who.int/publications/i/item/who-2019-nCoV-oral-health-2020.1 (accessed on 7 August 2020).
- Ren, S.Y.; Wang, W.B.; Hao, Y.G.; Zhang, H.R.; Wang, Z.C.; Chen, Y.L.; Gao, R.D. Stability and infectivity of coronaviruses in inanimate environments. World J. Clin. Cases 2020, 8, 1391–1399. [Google Scholar] [CrossRef]
- Kampf, G.; Todt, D.; Pfaender, S.; Steinmann, E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J. Hosp. Infect. 2020, 104, 246–251. [Google Scholar] [CrossRef] [Green Version]
- Marui, V.C.; Souto, M.L.S.; Rovai, E.S.; Romito, G.A.; Chambrone, L.; Pannuti, C.M. Efficacy of preprocedural mouthrinses in the reduction of microorganisms in aerosol: A systematic review. J. Am. Dent. Assoc. 2019, 150, 1015–1026e1011. [Google Scholar] [CrossRef]
- Ge, Z.Y.; Yang, L.M.; Xia, J.J.; Fu, X.H.; Zhang, Y.Z. Possible aerosol transmission of COVID-19 and special precautions in dentistry. J. Zhejiang Univ. Sci. B 2020, 21, 361–368. [Google Scholar] [CrossRef] [Green Version]
- Li, R.W.; Leung, K.W.; Sun, F.C.; Samaranayake, L.P. Severe acute respiratory syndrome (SARS) and the GDP. Part II: Implications for GDPs. Br. Dent. J. 2004, 197, 130–134. [Google Scholar] [CrossRef]
- Samaranayake, L.P.; Peiris, M. Severe acute respiratory syndrome and dentistry: A retrospective view. J. Am. Dent. Assoc. 2004, 135, 1292–1302. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Madarati, A.; Abid, S.; Tamimi, F.; Ezzi, A.; Sammani, A.; Shaar, M.; Zafar, M. Dental-Dam for Infection Control and Patient Safety during Clinical Endodontic Treatment: Preferences of Dental Patients. Int. J. Environ. Res. Public Health 2018, 15, 2012. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- American Dental Association. As Dental Practices Resume Operations, ADA Offers Continued Guidance. Available online: https://www.ada.org/en/press-room/news-releases/2020-archives/may/as-dental-practices-resume-operations-ada-offers-continued-guidance (accessed on 4 July 2020).
Background Characteristics | Dentists N = 590 | Dental Hygienists N = 235 | Dental Assistants N = 412 | Total Respondents N = 1237 |
---|---|---|---|---|
Sex * | ||||
Female | 468 (79%) | 227 (97%) | 411 (99.8%) | 1106 (89%) |
Male | 122 (21%) | 8 (3%) | 1 (0.2%) | 131 (11%) |
Age * | ||||
<30 | 73 (12%) | 50 (21%) | 35 (8%) | 158 (13%) |
30–40 | 229 (39%) | 64 (27%) | 75 (18%) | 368 (30%) |
41–50 | 151 (26%) | 51 (22%) | 110 (27%) | 312 (25%) |
51–60 | 87 (15%) | 43 (18%) | 124 (30%) | 254 (21%) |
>60 | 50 (8%) | 27 (12%) | 68 (17%) | 145 (11%) |
Work experience * | ||||
0–9 years | 216 (37%) | 84 (36%) | 89 (22%) | 389 (31%) |
>10 years | 374 (63%) | 151 (64%) | 323 (78%) | 848 (69%) |
Area of dental clinic * | ||||
Urban | 274 (46%) | 84 (36%) | 138 (33%) | 496 (40%) |
Peri-urban | 266 (45%) | 132 (56%) | 217 (53%) | 615 (50%) |
Rural | 50 (9%) | 19 (8%) | 57 (14%) | 126 (10%) |
Size of dental clinic | ||||
Large | 436 (74%) | 190 (81%) | 318 (77%) | 944 (76%) |
Small | 154 (26%) | 45 (19%) | 94 (23%) | 293 (24%) |
In which sector is your main workplace * | ||||
Public | 493 (84%) | 234 (99.6%) | 407 (99%) | 1134 (92%) |
Private | 97 (16%) | 1 (0.4%) | 5 (1%) | 103 (8%) |
County incidence categories * | ||||
High | 103 (17%) | 24 (10%) | 38 (9%) | 165 (13%) |
Medium | 311 (53%) | 127 (54%) | 216 (52%) | 654 (53%) |
Low | 176 (30%) | 84 (36%) | 158 (38%) | 418 (34%) |
Worked clinically with patients * | ||||
Yes | 413 (70%) | 66 (28%) | 248 (60%) | 727 (59%) |
No | 177 (30%) | 169 (72%) | 164 (40%) | 510 (41%) |
Urgent Dental Care Questions | Low Incidence Counties | Medium Incidence Counties | High Incidence Counties | Total Number of Responses |
---|---|---|---|---|
Information about patients inquired per phone * | ||||
Asking about symptoms (fever, cough, shortness of breath) | ||||
Always | 378 (90.4%) | 554 (84.7%) | 126 (76.4%) | 1058 (85.5%) |
Often | 30 (7.2%) | 71 (10.9%) | 23 (13.9%) | 124 (10.0%) |
Seldom | 1 (0.2%) | 21 (3.2%) | 10 (6.1%) | 32 (2.6%) |
Never | 5 (1.2%) | 4 (0.6%) | 2 (1.2%) | 11 (0.9%) |
I do not know | 4 (1.0%) | 4 (0.6%) | 4 (2.4%) | 12 (1.0%) |
Asking about history of travel to affected areas | ||||
Always | 337 (80.6%) | 488 (74.6%) | 115 (69.7%) | 940 (76.0%) |
Often | 52 (12.4%) | 86 (13.1%) | 26 (15.8%) | 164 (13.3%) |
Seldom | 14 (3.3%) | 56 (8.6%) | 8 (4.8%) | 78 (6.3%) |
Never | 8 (1.9%) | 12 (1.8%) | 4 (2.4%) | 24 (1.9%) |
I do not know | 7 (1.7%) | 12 (1.8%) | 12 (7.3%) | 31 (2.5%) |
How many patients NOT suspected to have COVID-19 have you treated (average per week) | ||||
Mean (SD) | 4.24 (4.7) | 4.52 (3.5) | 4.94 (7.2) | 4.50 (4.6) |
Median (range) | 3.00 | 4.00 | 3.00 | 3.00 |
How many patients have you treated per phone (average per week) | ||||
Mean (SD) | 12.32 | 9.42 | 11.11 | 10.58 |
Median (range) | 10.00 | 6.00 | 5.00 | 7.00 |
How many patients on average treated per phone received drug treatment (average per week) | ||||
Mean (SD) | 2.85 | 2.63 | 2.26 | 2.63 |
Median (range) | 2.00 | 2.00 | 1.00 | 1.00 |
When treating patients NOT suspected to have COVID-19, did you apply additional infection control measures | ||||
Yes | 117 (86.0%) | 217 (90.4%) | 55 83.3%) | 389 (88.0%) |
No | 12 (8.8%) | 20 (8.3%) | 9 (13.6%) | 41 (9.3%) |
I do not know | 7 (5.1%) | 3 (1.3%) | 2 (3.0%) | 12 (2.7%) |
How do you clean and disinfect room and equipment after having a patient * | ||||
70% ethyl alcohol | 394 (94.3%) | 592 (90.5%) | 135 (81.8) | 1121 (90.6%) |
Sodium hypochlorite at 0.5% (5000 ppm) | 6 (1.4%) | 3 (0.5%) | 2 (1.2%) | 11 (0.9%) |
Sodium hypochlorite at 0.1% (1000 ppm) | 8 (1.9%) | 9 (1.4%) | 5 (3.0%) | 22 (1.8%) |
Potassium peroxymonosulfate (Virkon) | 21 (5.0%) | 16 (2.4%) | 24 (14.5%) | 61 (4.9%) |
Disodium carbon (hydrogen peroxide (Perasafe)) | 32 (7.7%) | 19 (2.9%) | 25 (15.2%) | 76 (6.1%) |
Other | 396 (94.7%) | 591 (90.4%) | 145 (87.9%) | 1132 (91.5%) |
Which personal protection equipment did you use when treating patients | ||||
Respirators FFP2 or FFP3 standard or equivalent | 27 (19.9%) | 53 (22.1%) | 21 (31.8%) | 101 (22.9%) |
Gowns | 79 (58.1%) | 135 (56.3%) | 35 (53.0%) | 249 (56.3%) |
Surgical caps | 107 (78.7%) | 195 (81.3%) | 50 (75.8%) | 352 (79.6%) |
Medical masks | 132 (97.1%) | 238 (99.2%) | 63 (95.5%) | 433 (98.0%) |
Gloves | 132 (97.1%) | 239 (99.6%) | 64 (97.0%) | 435 (98.4%) |
Eye protection (googles or face shield) | 132 (97.1%) | 233 (97.1%) | 64 (97.0%) | 429 (97.1%) |
Apron | 73 (53.7%) | 136 (56.7%) | 35 (53.0%) | 244 (55.2%) |
Did you use any of the following as an additional protective measure while treating patients | ||||
Mouth rinse before a dental procedure * | 106 (78.5%) | 208 (87.0%) | 50 (75.8%) | 364 (82.7%) |
Rubber-dam * | 76 (56.3%) | 99 (41.4%) | 22 (33.3%) | 197 (44.8%) |
High volume suction * | 111 (82.2%) | 209 (87.4%) | 49 (74.2%) | 369 (83.9%) |
Chemo-mechanical caries removal | 5 (3.7%) | 9 (3.8%) | 4 (6.1%) | 18 (4.1%) |
Scheduling a patient where high-speed handpiece needs to be used as the last patient of the day | 52 (38.5%) | 109 (45.6%) | 23 (34.8%) | 184 (41.8%) |
Absorbable suture | 44 (32.6%) | 76 (31.8%) | 23 (34.8%) | 143 (32.5%) |
Extraoral dental radiographs as an alternative to intraoral radiographs | 19 (14.1%) | 28 (11.7%) | 8 (12.1%) | 55 (12.5%) |
Is your clinic designated to treat patients suspected or confirmed to have COVID-19? * | ||||
Yes | 94 (22.5%) | 54 (8.3%) | 22 (13.3%) | 170 (13.7%) |
No | 324 (77.5%) | 600 (91.7%) | 143 (86.7%) | 1067 (86.3%) |
If not, what do you do if such a patient requires urgent treatment * | ||||
I know clinics that are eligible to treat such patients | 319 (98.5%) | 593 (98.5%) | 129 (90.2%) | 1041 (97.4%) |
I do not know where such clinics are, but I know where to find the information on how to find them | 5 (1.5%) | 8 (1.3%) | 10 (7.0%) | 23 (2.2%) |
I do not know where such clinics are and where to find the information on how to find them | 0 (0.0%) | 1 (0.2%) | 4 (2.8%) | 5 (0.5%) |
Urgent Dental Care for Patients Suspected or Confirmed to Have COVID-19 | Low Incidence Counties | Medium Incidence Counties | High Incidence Counties | Total Number of Responses |
---|---|---|---|---|
How many patients suspected or confirmed to have COVID-19 have you treated (average per week) | ||||
Mean (SD) | 0.05 (0.3) | 0.03 (0.2) | 0.8 (4.1) | 0.05 (0.3) |
Median (range) | 0 (0; 3) | 0 (0; 2) | 0 (0; 32) | 0 (0; 32) |
How many patients suspected or confirmed to have COVID-19 have you treated (average per week) | ||||
None | 91 (96.3%) | 53 (97.9%) | 19 (89.4%) | 161 (94.5%) |
1–3 | 3 (3.7%) | 4 (2.1%) | 2 (7.5%) | 7 (4.4%) |
More than 3 | 0 (0%) | 0 (0%) | 1 (3.1%) * | 2 (1.0%) |
How long do you leave the room in between patients * | ||||
No limit | 2 (2.1%) | 0 (0.0%) | 0 (0.0%) | 2 (1.2%) |
35 min–3 h | 47 (50.0%) | 10 (18.2%) | 10 (45.5%) | 67 (39.2%) |
>3 h | 11 (11.7%) | 16 (29.1%) | 2 (9.1%) | 29 (17.0) |
Until the next day | 21 (22.3%) | 19 (34.5%) | 6 (27.3%) | 46 (26.9%) |
I do not know | 13 (13.8%) | 10 (18.2%) | 4 (18.2%) | 27 (15.8%) |
Which guidelines did you follow | ||||
Developed at county level | 52 (55.3%) | 23 (42.6%) | 9 (40.9%) | 84 (49.4%) |
Developed by a university | 25 (26.6%) | 22 (40.7%) | 12 (54.5%) | 59 (34.7%) |
I do not know | 7 (7.4%) | 2 (3.7%) | 0 (0.0%) | 9 (5.3%) |
Other | 10 (10.6%) | 7 (13.0%) | 1 (4.5%) | 18 (10.6%) |
Have you received a training in additional infection prevention and control guidelines * | ||||
Yes, digitally | 128 (69.2%) | 91 (55.8%) | 21 (47.7%) | 240 (61.2%) |
Yes, at the clinic | 41 (22.2%) | 30 (18.4%) | 17 (38.6%) | 88 (22.4%) |
No | 16 (8.6%) | 42 (25.8%) | 6 (13.6%) | 64 (16.3%) |
Has your clinic developed step-by-step procedures for treatment * | ||||
Yes | 93 (98.9%) | 47 (87.0%) | 22 (100.0%) | 162 (95.3%) |
No | 0 (0.0%) | 6 (11.1%) | 0 (0.0%) | 6 (3.5%) |
I do not know | 1 (1.1%) | 1 (1.9%) | 0 (0.0%) | 2 (1.2%) |
Have you received a training in step-by-step procedures for treatment | ||||
Yes | 86 (92.5%) | 37 (78.7%) | 20 (90.9%) | 143 (88.3%) |
No | 7 (7.5%) | 10 (21.3%) | 2 (9.1%) | 19 (11.7%) |
Have you received a simulation in step-by-step procedures for treatment | ||||
Yes | 60 (64.5%) | 31 (66.0%) | 12 (54.5%) | 103 (63.6%) |
No | 33 (35.5%) | 16 (34.0%) | 10 (45.5%) | 59 (36.4%) |
Have you experienced a deviation from step-by-step procedures | ||||
Yes | 12 (17.9%) | 12 (35.3%) | 3 (23.1%) | 27 (23.7%) |
No | 55 (82.1%) | 22 (64.7%) | 10 (76.9%) | 87 (76.3%) |
Have you been in need of an updated scientific information regarding treatment | ||||
Yes | 234 (71.6%) | 364 (66.8%) | 102 (71.3%) | 700 (69.0%) |
No | 93 (28.4%) | 181 (33.2%) | 41 (28.7%) | 315 (31.0%) |
If yes, was the information easily accessible | ||||
Yes | 57 (83.8%) | 31 (77.5%) | 12 (92.3%) | 100 (82.6%) |
No | 11 (16.2%) | 9 (22.5%) | 1 (7.7%) | 21 (17.4%) |
Which personal protection equipment was available at your workplace | ||||
Respirators FFP2 or FFP3 standard or equivalent * | 87 (92.6%) | 42 (77.8%) | 19 (86.4%) | 148 (87.1%) |
Gowns | 90 (95.7%) | 45 (83.3%) | 21 (95.5%) | 156 (91.8%) |
Surgical caps | 92 (97.9%) | 49 (90.7%) | 21 (95.5%) | 162 (95.3%) |
Medical masks | 94 (100%) | 52 (96.3%) | 21 (95.5%) | 167 (98.2%) |
Gloves | 94 (100.0%) | 52 (96.3%) | 21 (95.5%) | 167 (98.2%) |
Eye protection (googles or face shield) | 93 (98.9%) | 52 (96.3%) | 21 (95.5%) | 166 (97.6%) |
Apron * | 83 (11.7%) | 35 (64.8%) | 18 (81.8%) | 136 (80.0%) |
Which personal protection equipment did you use when treating patients | ||||
Respirators FFP2 or FFP3 standard or equivalent | 61 (89.7%) | 35 (92.1%) | 13 (100.0%) | 109 (91.6%) |
Gowns | 65 (95.6%) | 36 (94.7%) | 13 (100.0%) | 114 (95.8%) |
Surgical caps | 65 (95.6%) | 36 (94.7%) | 13 (100%) | 114 (95.8%) |
Medical masks | 56 (82.4%) | 34 (89.5%) | 12 (92.3%) | 102 (85.7%) |
Gloves | 66 (97.1%) | 7 (97.4%) | 13 (100.0%) | 116 (97.5%) |
Eye protection (googles or face shield) | 66 (97.1%) | 36 (94.7%) | 13 (100.0%) | 115 (96.6%) |
Apron | 28 (41.2%) | 20 (52.6%) | 6 (46.2%) | 54 (45.4%) |
Did you use any of the following as an additional protective measure while treating patients | ||||
Mouth rinse before procedure | 23 (85.2%) | 19 (100.0%) | 8 (100.0%) | 50 (92.6%) |
Rubber-dam | 19 (70.4%) | 12 (63.2%) | 3 (37.5%) | 34 (63.0%) |
High-volume saliva ejectors | 4 (14.8%) | 2 (10.5%) | 2 (25.0%) | 8 (14.8%) |
Chemo-mechanical caries removal | 1 (3.7%) | 1 (5.3%) | 1 (12.5%) | 3 (5.6%) |
Scheduling a patient where high-speed handpiece needs to be used as the last patient of the day | 20 (74.1%) | 14 (73.7%) | 6 (75.0%) | 40 (74.1%) |
Absorbable suture | 16 (59.3%) | 7 (36.8%) | 5 (62.5%) | 28 (51.9%) |
Extraoral dental radiographs as an alternative to intraoral radiographs * | 8 (29.6%) | 2 (10.5%) | 5 (62.5%) | 15 (27.8%) |
How do you clean and disinfect room and equipment after having a patient | ||||
70% ethyl alcohol | 67 (71.3%) | 41 (75.9%) | 17 (77.3%) | 125 (73.5%) |
Sodium hypochlorite at 0.5% (5000 ppm) | 5 (5.3%) | 2 (3.7%) | 0 (0%) | 7 (4.1%) |
Sodium hypochlorite at 0.1% (1000 ppm) | 3 (3.2%) | 2 (3.7%) | 0 (0%) | 5 (2.9%) |
Potassium peroxymonosulfate (Virkon) | 34 (36.2%) | 20 (37.0%) | 4 (18.2%) | 58 (34.1%) |
Disodium carbon with hydrogen peroxide (Perasafe) | 24 (25.5%) | 13 (24.1%) | 8 (36.4%) | 45 (26.5%) |
Do not know | 11 (11.7%) | 6 (11.1%) | 3 (13.6%) | 20 (11.8%) |
Other | 9 (9.6%) | 9 (16.7%) | 3 (13.6%) | 21 (12.4%) |
Independent Variables | Dental Staff Have a High Risk of Being Infected (Completely Agree/Agree) Adjusted i OR (95%CI) | If Workplace Has Adequate Infection Control Equipment (Completely Agree/Agree)Adjusted ii OR (95%CI) | If Workplace Handles Current Situation (Completely Agree/Agree)Adjusted iii OR (95%CI) | Workplace is Well Equipped to Handle an Escalation (Completely Agree/Agree) Adjusted iv OR (95%CI) |
---|---|---|---|---|
Sex | ||||
Male (ref) | 1 | 1 | 1 | 1 |
Female | 0.9 (0.5; 1.5) | 1.3 (0.8; 1.9) | 0.9 (0.5; 1.6) | 0.8 (0.5; 1.2) |
Work experience | ||||
>10 years (ref) | 1 | 1 | 1 | 1 |
0–9 years | 2.0 (1.4; 3.0) | 0.9 (0.7; 1.1) | 0.9 (0.6; 1.2) | 1.0 (0.8; 1.4) |
Profession | ||||
Specialist/General dental practitioner (ref) | 1 | 1 | 1 | 1 |
Dental hygienist | 0.8 (0.5; 1.3) | 1.3 (0.9; 1.8) | 1.6 (1.0; 2.5) | 1.5 (1.1; 2.2) |
Dental assistant | 1.0 (0.7; 1.5) | 1.1 (0.8; 1.5) | 1.5 (1.0; 2.1) | 1.4 (1.0; 1.9) |
Area of dental clinic | ||||
Urban (ref) | 1 | 1 | 1 | 1 |
Peri-urban | 1.3 (0.9; 1.8) | 0.9 (0.7; 1.1) | 0.9 (0.6; 1.2) | 1.1 (0.8; 1.4) |
Rural | 1.5 (0.7; 2.9) | 0.9 (0.6; 1.4) | 1.0 (0.6; 1.9) | 1.2 (0.7;1.9) |
Size of dental clinic | ||||
Large (ref) | 1 | 1 | 1 | 1 |
Small | 1.1 (0.7; 1.7) | 0.9 (0.7; 1.2) | 0.9 (0.6; 1.4) | 0.6 (0.5; 0.9) |
In which sector is your main workplace | ||||
Private (ref) | 1 | 1 | 1 | 1 |
Public | 2.4 (1.3; 4.4) | 0.3 (0.2; 0.5) | 0.2 (0.1; 0.5) | 0.2 (0.1; 0.4) |
County incidence categories | ||||
High (ref) | 1 | 1 | 1 | 1 |
Medium | 0.6 (0.3; 1.2) | 1.3 (0.9; 2.0) | 1.4 (0.8; 2.3) | 1.4 (0.9; 2.1) |
Low | 0.5 (0.3; 0.8) | 1.3 (0.9; 1.8) | 1.4 (0.8; 2.2) | 1.3 (0.8; 1.9) |
Worked clinically with patients during COVID-19 outbreak 13 March–17 April 2020 | ||||
Yes (ref) | 1 | 1 | 1 | 1 |
No | 0.8 (0.5; 1.1) | 0.9 (0.7; 1.1) | 1.2 (0.9; 1.7) | 1.1 (0.8; 1.4) |
Is your clinic designated to treat patients suspected or confirmed to have COVID-19? | ||||
Yes (ref) | 1 | 1 | 1 | 1 |
No | 1.3 (0.8; 2.1) | 0.6 (0.4; 0.9) | 0.9 (0.5; 1.4) | 0.3 (0.2; 0.4) |
First Author | Country | Date | Participants | Sample Size | Aim |
---|---|---|---|---|---|
Kamate [21] | Global Mostly represented by participants from Asia and Americas | December 25, 2019–February 20, 2020 | Dentists | 860 | Knowledge, attitudes and practices |
Quadri [22] | Saudi Arabia | March 2020 | Dental interns, dental auxiliaries, dental specialists | 706 | Current knowledge and plausible misconceptions |
Khader [23] | Jordan | March 2020 | Dentists | 368 | Awareness, perception and attitude |
Ahmed [24] | Global Mainly represented by Pakistan, Saudi Arabia, China and India | March 10–17, 2020 | Dentists | 650 | Fear and practice modification |
Duruk [25] | Turkey | March 16–20, 2020 | Dentists | 1958 | Clinical attitudes and behaviors |
Cagetti [26] | Italy | April 2020 | Dentists | 3599 | Symptoms/signs, protective measures, awareness, and perception |
Consolo [27] | Italy | April 2–21, 2020 | Dentists | 356 | Behaviors, emotions and concerns |
De Stefani [28] | Italy | April 11–18, 2020 | Dentists | 1500 | Knowledge, perception and attitude in treating potentially infected patients |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Stangvaltaite-Mouhat, L.; Uhlen, M.-M.; Skudutyte-Rysstad, R.; Szyszko Hovden, E.A.; Shabestari, M.; Ansteinsson, V.E. Dental Health Services Response to COVID-19 in Norway. Int. J. Environ. Res. Public Health 2020, 17, 5843. https://doi.org/10.3390/ijerph17165843
Stangvaltaite-Mouhat L, Uhlen M-M, Skudutyte-Rysstad R, Szyszko Hovden EA, Shabestari M, Ansteinsson VE. Dental Health Services Response to COVID-19 in Norway. International Journal of Environmental Research and Public Health. 2020; 17(16):5843. https://doi.org/10.3390/ijerph17165843
Chicago/Turabian StyleStangvaltaite-Mouhat, Lina, Marte-Mari Uhlen, Rasa Skudutyte-Rysstad, Ewa Alicja Szyszko Hovden, Maziar Shabestari, and Vibeke Elise Ansteinsson. 2020. "Dental Health Services Response to COVID-19 in Norway" International Journal of Environmental Research and Public Health 17, no. 16: 5843. https://doi.org/10.3390/ijerph17165843
APA StyleStangvaltaite-Mouhat, L., Uhlen, M. -M., Skudutyte-Rysstad, R., Szyszko Hovden, E. A., Shabestari, M., & Ansteinsson, V. E. (2020). Dental Health Services Response to COVID-19 in Norway. International Journal of Environmental Research and Public Health, 17(16), 5843. https://doi.org/10.3390/ijerph17165843